Company Filing History:
1 out of 75 
1 out of 832,843 Years Active: 2013-2014
Title: Jihong Dai: Innovator in Ex-Vivo Treatment of T-Cells
Introduction
Jihong Dai is a notable inventor based in Ambler, PA (US). He has made significant contributions to the field of medical diagnostics and treatment, particularly in the area of Th2-associated diseases. With a total of 2 patents, his work focuses on innovative methods for treating various disorders.
Latest Patents
Dai's latest patents include groundbreaking methods for ex-vivo treatment of T-cells using interferon lambda (IFN-λ). The first patent outlines a method for treating Th2-associated diseases by modulating the expression or secretion of interleukins IL-4, IL-5, and IL-13. This involves treating a patient's cells ex vivo with IFN-λ before returning them to the patient. The second patent similarly provides a method for ex-vivo treatment of peripheral blood leukocytes with IFN-λ, emphasizing the importance of this treatment in conjunction with co-administration of the interferon.
Career Highlights
Throughout his career, Jihong Dai has worked with various organizations, including Medical Diagnostics Laboratories, LLC. His expertise in the field has led to significant advancements in the treatment of Th2-associated diseases.
Collaborations
Dai has collaborated with notable professionals such as Grant E Gallagher and Nicholas Megjugorac, contributing to the development of innovative medical treatments.
Conclusion
Jihong Dai's contributions to the field of medical diagnostics and treatment through his patents on ex-vivo T-cell treatment highlight his role as a leading innovator. His work continues to impact the medical community positively.